231 related articles for article (PubMed ID: 18398511)
1. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
Samuelsson C; Hausmann J; Lauterbach H; Schmidt M; Akira S; Wagner H; Chaplin P; Suter M; O'Keeffe M; Hochrein H
J Clin Invest; 2008 May; 118(5):1776-84. PubMed ID: 18398511
[TBL] [Abstract][Full Text] [Related]
2. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
3. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
[TBL] [Abstract][Full Text] [Related]
4. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
5. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
6. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
[TBL] [Abstract][Full Text] [Related]
7. The Pathogenesis and Immunobiology of Mousepox.
Sigal LJ
Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
[TBL] [Abstract][Full Text] [Related]
8. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
[TBL] [Abstract][Full Text] [Related]
9. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Knitlova J; Hajkova V; Voska L; Elsterova J; Obrova B; Melkova Z
PLoS One; 2014; 9(12):e114374. PubMed ID: 25486419
[TBL] [Abstract][Full Text] [Related]
10. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.
Siciliano NA; Hersperger AR; Lacuanan AM; Xu RH; Sidney J; Sette A; Sigal LJ; Eisenlohr LC
J Virol; 2014 Sep; 88(17):10078-91. PubMed ID: 24965457
[TBL] [Abstract][Full Text] [Related]
11. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
12. [The resistance of a maternally-derived immunity of baby mice against mousepox--experiments regarding a special possibility of immunization with orthopox viruses (author's transl)].
Munz E; Reimann M; Kaufmann R
Zentralbl Bakteriol B; 1979; 169(5-6):495-509. PubMed ID: 232602
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.
Robbins SJ; Jackson RJ; Fenner F; Beaton S; Medveczky J; Ramshaw IA; Ramsay AJ
Antiviral Res; 2005 Apr; 66(1):1-7. PubMed ID: 15781125
[TBL] [Abstract][Full Text] [Related]
14. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
15. Correlates of protective immunity in poxvirus infection: where does antibody stand?
Panchanathan V; Chaudhri G; Karupiah G
Immunol Cell Biol; 2008 Jan; 86(1):80-6. PubMed ID: 17923850
[TBL] [Abstract][Full Text] [Related]
16. Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.
O'Gorman WE; Sampath P; Simonds EF; Sikorski R; O'Malley M; Krutzik PO; Chen H; Panchanathan V; Chaudhri G; Karupiah G; Lewis DB; Thorne SH; Nolan GP
Cell Host Microbe; 2010 Aug; 8(2):174-85. PubMed ID: 20709294
[TBL] [Abstract][Full Text] [Related]
17. Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara.
Staib C; Suezer Y; Kisling S; Kalinke U; Sutter G
J Gen Virol; 2006 Oct; 87(Pt 10):2917-2921. PubMed ID: 16963750
[TBL] [Abstract][Full Text] [Related]
18. Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.
Barnowski C; Ciupka G; Tao R; Jin L; Busch DH; Tao S; Drexler I
Front Immunol; 2020; 11():1458. PubMed ID: 32765505
[TBL] [Abstract][Full Text] [Related]
19. Chronic Lymphocytic Choriomeningitis Infection Causes Susceptibility to Mousepox and Impairs Natural Killer Cell Maturation and Function.
Alves-Peixoto P; Férez M; Knudson CJ; Stotesbury C; Melo-Silva CR; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776282
[TBL] [Abstract][Full Text] [Related]
20. Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.
Lauterbach H; Kassub R; Pätzold J; Körner J; Brückel M; Verschoor A; Chaplin P; Suter M; Hochrein H
PLoS One; 2010 Mar; 5(3):e9659. PubMed ID: 20300179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
